Leprosy Treatment In India: How Dermatologists, Alternative Therapies, And Modern Medicine Are Changing Lives

Can integrative medicine transform leprosy care in India? Read on to know how dermatology, CAM, and new therapies are reshaping treatment and recovery for patients.

Leprosy is a stigmatizing and disabling disease caused by infection with Mycobacterium leprae, followed by a persistent inflammation immune attack against the bacterial antigen. According to Dr. Astha Gupta, Consultant - Dermatology, Sarvodaya Hospital, Faridabad, an integrated and multidisciplinary strategy is key to successful management and community reintegration for individuals with leprosy.

Role of Dermatology in Leprosy Management

Dermatology is considered the most suitable profession to lead management in general health services, as the profession has much to offer as a resource for diagnosis and education. However, an integrated approach in the future of leprosy control in India is needed by involving professionals from different systems of medicine and coordinated by dermatologists working in the field of community dermatology.

Traditional healers in India face low education, leading to misdiagnosis and inappropriate treatment. Health education is crucial for prompt treatment and rehabilitation services. Training improves knowledge of leprosy, allowing early detection and referral.

Apart from the MDT and PDT, used for treatment of leprosy, which includes drugs like Rifampicin, Dapsone, Clofazimine, the pharmacological treatment of nociceptive pain in individuals with leprosy is carried out using corticosteroids, thalidomide or non-hormonal anti-inflammatory drugs, and for neuropathic pain, anticonvulsants, tricyclic or neuroleptic antidepressants are used, but users do not well tolerate some drugs because of their side effects

Benefits and Cautions of Complementary and Integrative Practices (CIPs)

Integrative and complementary practices (CIPs) like acupuncture, homeopathy, herbal medicine, anthroposophic medicine, and crenotherapy should be included in leprosy treatment. These practices improve morbidity, reduce medication use, and enhance users' quality of life.

Even though CIPs do not involve invasive procedures or high risk, they should be administered carefully, with an understanding of the capabilities and limitations offered by these therapies, and information on these treatments should not be generalized to avoid the use of inappropriate treatments for particular types of pain, or even aggravating the disease of their users.

The lack of information about CIPs and insecurity among health services managers about their use has hindered patient adherence to this treatment. Health professionals must advise and train patients on CIPs' benefits and potential adverse effects, while receiving proper encouragement and training in this rapidly changing subject.

Expert View: Combining MDT with Integrative Care

According to Dr. Sandeep S. Reddy, Lead Consultant in Infectious Diseases at Ramaiah Memorial Hospital, while MDT remains the cornerstone of leprosy treatment, integrative and alternative therapies are increasingly crucial in delivering comprehensive care. In many parts of the world, populations depend on Complementary and Alternative Medicine (CAM) to address their healthcare needs, especially for managing chronic conditions. Combining conventional treatments with holistic therapies has shown to enhance outcomes and improve overall patient well-being.

The integration of immunotherapy, particularly the MIP vaccine, alongside traditional MDT has shown promising results in enhancing treatment efficacy. Additionally, innovative approaches such as platelet-rich plasma therapy for ulcer management and customized antibiotic protocols based on susceptibility testing represent significant advances in leprosy care.

Rehabilitative surgery, when combined with physiotherapy and occupational therapy, has proven crucial in preventing disabilities and deformities. There have been encouraging results with alternative therapeutic modalities such as yoga and meditation for pain management and psychological support, as well as nutritional interventions to boost immune function.

However, the lack of information about the existence and use of CAMs, and financial reasons, such as not being able to afford the CAMs or be able to travel to the location where the service was being offered are the main barriers to adherence to Complimentary-Integrative practices. Inadequate training and encouragement for healthcare professionals, with a general lack of infrastructure, also limited their use.

The future of leprosy care lies in a more personalized, integrative approach that addresses not just the bacterial infection but comprehensive care. This includes early detection through advanced diagnostic algorithms, monitoring treatment response with newer technologies, and considering drug repurposing options like bedaquiline for resistant cases. The key is to maintain a balance between evidence-based conventional treatments and complementary therapies that can enhance healing and rehabilitation while improving the patient's overall well-being.